By Ransdell Pierson (Reuters) - Eli Lilly and Co, which is trying to rebound from painful patent expirations on its medicines, said on Thursday that it would have to cut costs to achieve its financial goals through 2014. Shares of the U.S. drugmaker fell more than 3 percent even though it also said it would buy back $5 billion of its stock over time. Lilly said slowing growth in emerging markets and the devaluation of Japan's yen were hurting its results. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment